Dongyang Guangyao submitted a prospectus to be listed in Hong Kong by way of introduction. On December 11th, Dongyangguang Pharmaceutical, the controlling shareholder of Dongyangguang Changjiang Pharmaceutical, submitted a prospectus to the Hong Kong Stock Exchange to be listed in Hong Kong by way of introduction, and the exclusive sponsor was CICC.Tianyu Bio staged the "Heaven and Earth" market in the afternoon, with a turnover of over 900 million yuan.For the first time, Nanjing Port docked with container ships of "longest ship scale" and "maximum load". Today (December 12th) morning, the largest container ship that entered the port since the opening of Nanjing Port, Panamanian vessel "Mai Di Hong Wei", successfully docked at Longtan Container Terminal, setting a new "double historical record" for the longest scale and maximum load of container ships entering the port. It is understood that the ship is 208.3 meters long, 29.8 meters wide and 33,715 tons deadweight. This voyage is a direct flight from Europe to Nanjing, which will directly increase the maximum container capacity of incoming ships from the current 1938TEU (standard container) to 2600TEU. The successful berthing indicates that 30,000-ton container ships can enter and leave Nanjing Port normally. (CCTV News)
Zhongding Co., Ltd. established a subsidiary of Robotics Technology. Tianyancha APP shows that Anhui Ruisibo Robotics Technology Co., Ltd. was recently established, with Xia Yingsong as its legal representative and a registered capital of 50 million yuan. Its business scope includes: research and development of intelligent robots; Intelligent robot sales; Industrial robot manufacturing; Industrial robot sales and so on. Tianyancha's equity penetration shows that the company is wholly owned by Zhongding.Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement.Korean media: The director of the South Korean Police Department who was arrested in an emergency for "civil strife" was sent to the hospital due to the deterioration of his health. According to Yonhap News Agency's latest news from the police on the 12th, Zhao Zhihao, the director of the South Korean Police Department who was arrested in an emergency on suspicion of "civil strife" in the early morning of the 11th, has been sent to the hospital for treatment due to the deterioration of his health. (World Wide Web)
The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)South Korea's finance ministers and Japan's finance ministers held an online meeting, and the two sides reiterated the importance of the partnership between the two countries.The average annual salary of doctors is 690,000, and the fixed income accounts for 70%. On the afternoon of December 10th, National Health Commission held a press conference in Shenzhen around the promotion of Sanming's medical reform experience. Relevant officials in Guangdong, Guangzhou and Shenzhen introduced the local medical reform including centralized procurement, price adjustment and salary reform. In 2012, the Shenzhen Municipal People's Government fully invested in introducing the modern management mode of the University of Hong Kong and established the Shenzhen Hospital of the University of Hong Kong. From the details of space design and department name, we can feel that this hospital is different from ordinary mainland hospitals, and the difference in internal system may be even greater-the average annual salary of doctors in this hospital is 690,000 yuan, which is 4.8 times that of the local social wage, of which the fixed salary accounts for 70% and the performance appraisal is 30%. Generally speaking, performance income accounts for a large part of doctors' income. The reporter interviewed two doctors in tertiary hospitals in Beijing, and their performance pay accounted for about 60-70%, which was significantly higher than the fixed salary. In a set of internal data presented by Xu Xiaoping, secretary of the Party Committee of Shenzhen Hospital of the University of Hong Kong, the salary structure of three well-known 3A hospitals in Beijing, Sichuan and Zhejiang is listed, showing that the proportion of fixed income ranges from 20% to 47%. (Beijing News)
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14